Zhong Guo Jing Ji Wang·2026-01-28 06:20Core Viewpoint - Fosun Pharma (600196.SH) announced the progress of guarantees provided for its subsidiaries, with total external guarantees amounting to approximately RMB 2,276,279 million, representing 48.16% of the audited net assets attributable to shareholders as of December 31, 2024 [1][2]. Group 1: Guarantee Details - As of January 27, 2026, the total amount of external guarantees, including the current guarantee, is approximately RMB 2,276,279 million [2]. - The company has no overdue guarantee matters as of January 27, 2026 [1]. - On January 26, 2026, the company entered into a guarantee contract with Bank of Communications, agreeing to provide a maximum joint liability guarantee for its subsidiary Fosun Pharma Industry for a financing contract not exceeding RMB 112,900 million [3]. Group 2: Credit Facilities and Agreements - On September 11, 2025, Fosun Yalifeng, a subsidiary, signed a credit agreement with China Merchants Bank for a credit limit of RMB 4,500 million, which was later increased to RMB 10,000 million [3]. - On January 26, 2026, Fosun Health signed a working capital loan agreement with Bank of Communications for a loan limit of RMB 5,000 million [4]. - Fosun Health also entered into factoring agreements with Agricultural Bank and Dalian Bank for financing limits of RMB 3,000 million and RMB 10,000 million, respectively [5][6]. Group 3: Additional Guarantees - On January 27, 2026, subsidiary Suzhou Erye signed a guarantee contract with Bank of Communications for a financing contract not exceeding RMB 6,000 million [6]. - On the same day, Beijing Beiling applied for a loan of RMB 1,500 million from Beijing Rural Commercial Bank, with Fosun Beiling providing a joint liability guarantee [7].